MapLight
PrivateLast Round
IPO
10/29/2025
Est. Valuation
$704.3M
Total Funding Raised
$649.1M
Momentum Score
25 /100
Company Overview
MapLight is a biopharmaceutical company focused on discovering innovative treatments for brain disorders through proprietary optogenetics and a 3D spatial transcriptomics platform to develop targeted therapies for serious CNS conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MapLight Comps
Public and private peers based on sector, stage, and business model.
MapLight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | 10/29/2025 | ||||
| Series D | 7/28/2025 | ||||
| Series C | 10/30/2023 | ||||
| Grant | 8/4/2021 | ||||
| Series B | 2/1/2021 | ||||
Grant | 11/30/2020 |
Key People
Founding team and executive leadership
MapLight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | IPO |
| Forbion | Series D |
| Life Sciences at Goldman Sachs Alternatives | Series D |
| TD Securities | Series C |
| 5AM Ventures | Series D, Series C, Series A, Series B, Seed |
| Avego BioScience Capital | Series D |
| Morgan Stanley | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2026
Partnered with Flex Databases for integrated CTMS and eTMF platform.
- Mar 11, 2026
ML-007 for Schizophrenia is in Phase 2/3 clinical trials.
MapLight Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MapLight's valuation, stock price, and market status.
